BridgeBio(BBIO) - 2023 Q1 - Earnings Call Presentation
BBIOBridgeBio(BBIO)2023-03-02 01:40

Corporate Presentation Forward-Looking Statements and Disclaimer Statements in this Presentation that are not statements of historical fact are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding BridgeBio Pharma, Inc.’s (the “Company’s”)R35-year vision for $2bn+ in product sales and 8 Ph3 readouts, research ...